Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Ebert

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
International Journal of Behavioral Medicine|April 10, 2026
Patient Views on a Pre-treatment Blood Test to Predict Outcomes Following PD-1 Inhibitor Therapy: A Qualitative StudyAmy Jarvis, Sarah Vincent, Amanda D Hutchinson, et al.
Clinical & Translational Immunology|April 25, 2017
Control of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy?Lih Yin Tan, Carmela Martini, Zvi G Fridlender, et al.
Biochemical Society Transactions|March 24, 2019
Glioblastoma heterogeneity and the tumour microenvironment: implications for preclinical research and development of new treatmentsSally L Perrin, Michael S Samuel, Barbara Koszyca, et al.
BMC Cancer|July 3, 2021
CD36 promotes vasculogenic mimicry in melanoma by mediating adhesion to the extracellular matrixCarmela Martini, Mark DeNichilo, Danielle P King, et al.
European Journal of Immunology|November 6, 2012
Flt3 ligand expands CD4+ FoxP3+ regulatory T cells in human subjectsOliver Klein, Lisa M Ebert, Damien Zanker, et al.
Scientific Reports|April 5, 2020
Platelets disrupt vasculogenic mimicry by cancer cellsCarmela Martini, Emma J Thompson, Stephanie R Hyslop, et al.
Frontiers in Oncology|January 8, 2024
Desmoglein-2 as a cancer modulator: friend or foe?Kay K Myo Min, Charlie B Ffrench, Barbara J McClure, et al.
Clinical & Translational Immunology|July 8, 2024
Endogenous bystander killing mechanisms enhance the activity of novel FAP-specific CAR-T cells against glioblastomaWenbo Yu, Nga Th Truong, Ruhi Polara, et al.
Oncotarget|January 11, 2014
FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosisBeeShin Tan, Matthew Anaka, Siddhartha Deb, et al.
Stem Cell Research|April 23, 2015
Interleukin-3 greatly expands non-adherent endothelial forming cells with pro-angiogenic propertiesLachlan M Moldenhauer, Michaelia P Cockshell, Lachlan Frost, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
International Journal of Behavioral Medicine|April 10, 2026
Patient Views on a Pre-treatment Blood Test to Predict Outcomes Following PD-1 Inhibitor Therapy: A Qualitative StudyAmy Jarvis, Sarah Vincent, Amanda D Hutchinson, et al.
Clinical & Translational Immunology|April 25, 2017
Control of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy?Lih Yin Tan, Carmela Martini, Zvi G Fridlender, et al.
Biochemical Society Transactions|March 24, 2019
Glioblastoma heterogeneity and the tumour microenvironment: implications for preclinical research and development of new treatmentsSally L Perrin, Michael S Samuel, Barbara Koszyca, et al.
BMC Cancer|July 3, 2021
CD36 promotes vasculogenic mimicry in melanoma by mediating adhesion to the extracellular matrixCarmela Martini, Mark DeNichilo, Danielle P King, et al.
European Journal of Immunology|November 6, 2012
Flt3 ligand expands CD4+ FoxP3+ regulatory T cells in human subjectsOliver Klein, Lisa M Ebert, Damien Zanker, et al.
Scientific Reports|April 5, 2020
Platelets disrupt vasculogenic mimicry by cancer cellsCarmela Martini, Emma J Thompson, Stephanie R Hyslop, et al.
Frontiers in Oncology|January 8, 2024
Desmoglein-2 as a cancer modulator: friend or foe?Kay K Myo Min, Charlie B Ffrench, Barbara J McClure, et al.
Clinical & Translational Immunology|July 8, 2024
Endogenous bystander killing mechanisms enhance the activity of novel FAP-specific CAR-T cells against glioblastomaWenbo Yu, Nga Th Truong, Ruhi Polara, et al.
Oncotarget|January 11, 2014
FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosisBeeShin Tan, Matthew Anaka, Siddhartha Deb, et al.
Stem Cell Research|April 23, 2015
Interleukin-3 greatly expands non-adherent endothelial forming cells with pro-angiogenic propertiesLachlan M Moldenhauer, Michaelia P Cockshell, Lachlan Frost, et al.
Pageof 6